MedTrace Logo

Randomized Masked Trial of Injectable Cross-Linked Hyaluronic Acid for Moderate-to-Severe Nasolabial Folds

NCT07367204 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 356

Last updated 2026-01-26

No results posted yet for this study

Summary

The objective of this clinical trial is to evaluate the efficacy and safety of injectable cross - linked hyaluronic acid gel for correcting moderate to severe nasolabial fold wrinkles, on the premise of ensuring the safety of subjects and the scientific rigor of the clinical trial.

Conditions

  • Nasolabial Fold Wrinkles

Interventions

DEVICE

Intense

Correction of moderate to severe nasolabial fold wrinkles

DEVICE

Restylane

the Correction of Midface Volume Deficiency and/or Midface Contour Deficiency

Sponsors & Collaborators

  • Chongqing Jinsaixing Medical Technology Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-24
Primary Completion
2026-04-26
Completion
2027-03-06

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07367204 on ClinicalTrials.gov